Article
Follistatin N terminus differentially regulates muscle size and fat in vivo.
Experimental & molecular medicine - 15 Sept 2017
Zheng Hui, Qiao Chunping, Tang Ruhang, Li Jianbin, Bulaklak Karen, Huang Zhenhua, Zhao Chunxia, Dai Yi, Li Juan, Xiao Xiao
Abstract excerpt
Delivery of follistatin (FST) represents a promising strategy for both muscular dystrophies and diabetes, as FST is a robust antagonist of myostatin and activin, which are critical regulators of skeletal muscle and adipose tissues. FST is a multi-domain protein, and deciphering the function of different domains will facilitate novel designs for FST-based therapy. Our study aims to investigate the role of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
